By: IPP Bureau
Last updated : November 16, 2024 5:00 pm
Total Income in Q2 FY25 stood at Rs. 532.18 crore
IOL Chemicals and Pharmaceuticals Ltd, a leading manufacturer of pharmaceutical APIs and speciality chemicals, announced its financial results for the second quarter and half year ended 30th September 2024.
The company has posted PAT of Rs. 19.15 crore in Q2 FY25 as compared to Rs. 37.79 crore, reflecting a drop of 49 per cent. Total Income in Q2 FY25 stood at Rs. 532.18 crore as compared to Rs. 552.41 in Q2 FY24. EBITDA in Q2 FY25 was Rs. 47.99 crore as compared to Rs. 71.21 crore in Q2 FY24.
Commenting on the performance, Vikas Gupta, Joint Managing Director said, "We are pleased to report sustainable revenue growth in Q2 FY25, reflecting the resilience of our core business. However, we faced some margin pressure during the quarter, driven by challenges in selling price. To address this, we are taking proactive measures to optimize marketing strategies, cost structure and enhance operational efficiencies, with the goal of improving profitability in the coming periods. Despite these challenges, we remain confident in the long-term growth potential of the business."